Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Switching to Atripla in HIV patients with raised cholesterol (ROCKET I)
NCT00615810Phase 4Completed
- Sponsor
- Gilead Sciences
- Start
- Mar 2008
- Primary completion
- Oct 2009
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of tenofovir disoproxil fumarate in human immunodeficiency virus infection (HIV), sponsored by Gilead Sciences. Started Mar 2008; status: completed.
02
Drugs
tenofovir disoproxil fumarate
03
Conditions
human immunodeficiency virus infection (HIV)
Beyond the preview
Go deeper on NCT00615810.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00615810.